Literature DB >> 21905016

Defective DNA double-strand break repair in pediatric systemic lupus erythematosus.

Robert C Davies1, Kelly Pettijohn, Francesca Fike, Jiexi Wang, Shareef A Nahas, Rashmi Tunuguntla, Hailiang Hu, Richard A Gatti, Deborah McCurdy.   

Abstract

OBJECTIVE: Previous reports of cells from patients with systemic lupus erythematosus (SLE) note that repair of single-strand breaks is delayed, and these lesions may be converted to double-strand breaks (DSBs) at DNA replication forks. We undertook this study to assess the integrity of DSB recognition, signaling, and repair mechanisms in B lymphoblastoid cell lines derived from patients with pediatric SLE.
METHODS: Nine assays were used to interrogate DSB repair and recognition in lymphoblastoid cell lines from patients with pediatric SLE, including the neutral comet assay (NCA), colony survival assay (CSA), irradiation-induced foci formation for γ-H2AX and 53BP1 proteins, kinetics of phosphorylation of structural maintenance of chromosomes protein 1 (SMC1), postirradiation bromodeoxyuridine incorporation to evaluate S phase checkpoint integrity, monoubiquitination of Fanconi protein D2, ATM protein expression, and non-homologous DNA end joining protein expression and function.
RESULTS: Three of the 9 assays revealed abnormal patterns of response to irradiation-induced DNA damage. The NCA and CSA yielded aberrant results in the majority of SLE lymphoblastoid cell lines. Abnormal prolongation of SMC1 phosphorylation was also noted in 2 of 16 SLE lymphoblastoid cell lines.
CONCLUSION: Our data suggest that DSB repair is defective in some lymphoblastoid cell lines from pediatric patients with SLE, especially when assessed by both NCA and CSA. Since these studies are nonspecific, further studies of DNA repair and kinetics are indicated to further delineate the underlying pathogenesis of SLE and possibly identify therapeutic targets.
Copyright © 2012 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2012        PMID: 21905016     DOI: 10.1002/art.33334

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  21 in total

1.  SMRT compounds abrogate cellular phenotypes of ataxia telangiectasia in neural derivatives of patient-specific hiPSCs.

Authors:  Peiyee Lee; Nathan T Martin; Kotoka Nakamura; Soheila Azghadi; Mandana Amiri; Uri Ben-David; Susan Perlman; Richard A Gatti; Hailiang Hu; William E Lowry
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

2.  Estrogen receptor alpha promotes lupus in (NZB×NZW)F1 mice in a B cell intrinsic manner.

Authors:  Dana E Tabor; Karen A Gould
Journal:  Clin Immunol       Date:  2016-10-29       Impact factor: 3.969

Review 3.  Recent developments in systemic lupus erythematosus pathogenesis and applications for therapy.

Authors:  Mindy S Lo; George C Tsokos
Journal:  Curr Opin Rheumatol       Date:  2018-03       Impact factor: 5.006

Review 4.  DNA repair and systemic lupus erythematosus.

Authors:  Rithy Meas; Matthew J Burak; Joann B Sweasy
Journal:  DNA Repair (Amst)       Date:  2017-06-09

5.  LIG4 and RAD52 DNA repair genes polymorphisms and systemic lupus erythematosus.

Authors:  Jaqueline De Azevêdo Silva; João Alexandre Trés Pancotto; Eduardo Antônio Donadi; Sergio Crovella; Paula Sandrin-Garcia
Journal:  Mol Biol Rep       Date:  2014-01-12       Impact factor: 2.316

6.  Heterozygote FANCD2 mutations associated with childhood T Cell ALL and testicular seminoma.

Authors:  Stephanie Smetsers; Joanne Muter; Claire Bristow; Leena Patel; Kate Chandler; Denise Bonney; Robert F Wynn; Anthony D Whetton; Andrew M Will; Davy Rockx; Hans Joenje; Gordon Strathdee; Jonathan Shanks; Eva Klopocki; Johan J P Gille; Josephine Dorsman; Stefan Meyer
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

Review 7.  DNA-damaging autoantibodies and cancer: the lupus butterfly theory.

Authors:  Philip W Noble; Sasha Bernatsky; Ann E Clarke; David A Isenberg; Rosalind Ramsey-Goldman; James E Hansen
Journal:  Nat Rev Rheumatol       Date:  2016-03-24       Impact factor: 20.543

Review 8.  The danger model approach to the pathogenesis of the rheumatic diseases.

Authors:  César Pacheco-Tena; Susana Aideé González-Chávez
Journal:  J Immunol Res       Date:  2015-04-20       Impact factor: 4.818

Review 9.  DNA Damage Response in the Adaptive Arm of the Immune System: Implications for Autoimmunity.

Authors:  Theodora Manolakou; Panayotis Verginis; Dimitrios T Boumpas
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

10.  ATM-dependent MiR-335 targets CtIP and modulates the DNA damage response.

Authors:  Nathan T Martin; Kotoka Nakamura; Robert Davies; Shareef A Nahas; Christina Brown; Rashmi Tunuguntla; Richard A Gatti; Hailiang Hu
Journal:  PLoS Genet       Date:  2013-05-16       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.